Article Versions Notes

Zhou Q, Doherty J, Akk A, Springer LE, Fan P, Spasojevic I, Halade GV, Yang H, Pham CTN, Wickline SA, et al. Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury. Nanomaterials. 2022; 12(3):336. https://doi.org/10.3390/nano12030336

Zhou, Qingyu, Justin Doherty, Antonina Akk, Luke E. Springer, Ping Fan, Ivan Spasojevic, Ganesh V. Halade, Huanghe Yang, Christine T. N. Pham, Samuel A. Wickline, and et al. 2022. "Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury" Nanomaterials 12, no. 3: 336. https://doi.org/10.3390/nano12030336

Zhou, Q., Doherty, J., Akk, A., Springer, L. E., Fan, P., Spasojevic, I., Halade, G. V., Yang, H., Pham, C. T. N., Wickline, S. A., & Pan, H. (2022). Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury. Nanomaterials, 12(3), 336. https://doi.org/10.3390/nano12030336